{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:44:20Z","timestamp":1792205060914,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.urology.2025.09.023","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T05:43:36Z","timestamp":1758692616000},"page":"66-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trends in Urogynecologic and Reconstructive Pelvic Surgery Among Early-career Urologists: Analysis of American Board of Urology Case Logs From 2009-2020"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6409-3803","authenticated-orcid":false,"given":"Zhenyue","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Ieong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Weissbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.09.023_bib1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/AOG.0b013e3181c2ce96","article-title":"Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050","volume":"114","author":"Wu","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2025.09.023_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33864","article-title":"Projected US urology workforce per capita, 2020-2060","volume":"4","author":"Nam","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urology.2025.09.023_bib3","doi-asserted-by":"crossref","first-page":"335.e9","DOI":"10.1016\/j.urolonc.2024.09.034","article-title":"Urologic oncology case volume among early career urologists: an analysis of certification data from the American Board of Urology between 2003 and 2019","volume":"43","author":"Shukla","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2025.09.023_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/nau.22942","article-title":"Disparities in female urologic case distribution with new subspecialty certification and surgeon gender","volume":"36","author":"Liu","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib5","unstructured":"US Food and Drug Administration. FDA approves Botox to treat overactive bladder. Press release. January 18, 2013 (updated January 22, 2013). Archived at Wayback Machine: https:\/\/wayback.archive-it.org\/7993\/20161022204431\/https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm336101.htm. Accessed October 5th, 2025."},{"key":"10.1016\/j.urology.2025.09.023_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.urology.2019.03.028","article-title":"Fellowship and subspecialization in urology: an analysis of robotic-assisted partial nephrectomy","volume":"130","author":"Omidele","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.09.023_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/nau.25247","article-title":"Current exposure to Female Pelvic Medicine and Reconstructive Surgery faculty during urology residency","volume":"42","author":"Wang","year":"2023","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib8","unstructured":"American Board of Obstetrics and Gynecology. ABOG and ABU rename subspecialty to Urogynecology and Reconstructive Pelvic Surgery. News release. October 4, 2023. Updated October 5, 2023. Available from: https:\/\/www.abog.org\/about-abog\/news-announcements\/2023\/10\/05\/abog-and-abu-rename-subspecialty-to-urogynecology-and-reconstructive-pelvic-surgery. Accessed October 5, 2025."},{"key":"10.1016\/j.urology.2025.09.023_bib9","unstructured":"U.S. Food and Drug Administration. FDA takes action to protect women\u2019s health; orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices. Press release. April 16, 2019. Available from: https:\/\/www.fda.gov\/medical-devices\/urogynecologic-surgical-mesh-implants\/fdas-activities-urogynecologic-surgical-mesh. Accessed October 5, 2025."},{"key":"10.1016\/j.urology.2025.09.023_bib10","unstructured":"U.S. Food and Drug Administration. UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Safety communication. July 13, 2011. Available from: https:\/\/www.fda.gov\/medical-devices\/urogynecologic-surgical-mesh-implants\/fdas-activities-urogynecologic-surgical-mesh. Accessed October 5, 2025."},{"key":"10.1016\/j.urology.2025.09.023_bib11","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"Onabotulinumtoxin\u00a0A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.09.023_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/nau.22544","article-title":"Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder","volume":"34","author":"Siegel","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib13","first-page":"S17","article-title":"Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder","volume":"37","author":"Blok","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/nau.23482","article-title":"The novel Axonics\u00ae rechargeable sacral neuromodulation system: procedural and technical impressions from an initial North American experience","volume":"37","author":"Elterman","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/nau.25171","article-title":"Evaluation of clinical performance and safety for the rechargeable InterStim Micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study","volume":"42","author":"Goudelocke","year":"2023","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2025.09.023_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ner.12695","article-title":"Sacral neuromodulation: standardized electrode placement technique","volume":"20","author":"Matzel","year":"2017","journal-title":"Neuromodulation"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525008994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525008994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:08:36Z","timestamp":1780722516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525008994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":16,"alternative-id":["S0090429525008994"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.09.023","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Urogynecologic and Reconstructive Pelvic Surgery Among Early-career Urologists: Analysis of American Board of Urology Case Logs From 2009-2020","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}